Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Pagel

Showing results (51-60 of 245) with videos related to

Pageof 25
Sort By:
Journal of Molecular Biology|April 20, 1992
DNA topology-mediated regulation of transcription initiation from the tandem promoters of the ilvGMEDA operon of Escherichia coliJ M Pagel, J W Winkelman, C W Adams, et al.
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passé Yet?Alexey V Danilov, John M Pagel, Jennifer R Brown, et al.
Analytical Chemistry|November 24, 1999
Mass spectrometric analysis of benzoylated sialooligosaccharides and differentiation of terminal alpha 2-->3 and alpha 2-->6 sialogalactosylated linkages at subpicomole levelsP Chen, U Werner-Zwanziger, D Wiesler, et al.
Cancer Research|November 1, 1981
Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modificationE A Neuwelt, M Pagel, P Barnett, et al.
Neurosurgery|January 1, 1983
Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrierE A Neuwelt, P Barnett, J Barranger, et al.
American Journal of Hematology|August 19, 2007
Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)John M Pagel, Jack Lionberger, Ajay K Gopal, et al.
Chemical Research in Toxicology|July 22, 1998
Reaction of N-acetylglycyllysine methyl ester with 2-alkenals: an alternative model for covalent modification of proteinsA Baker, L Zídek, D Wiesler, et al.
Cancer Research|April 6, 2006
A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignanciesYukang Lin, John M Pagel, Donald Axworthy, et al.
Proceedings of Spie--The International Society for Optical Engineering|October 1, 2016
Multimodality pH imaging in a mouse dorsal skin fold window chamber modelHui Min Leung, Rachel Schafer, Mark M Pagel, et al.
Blood|April 1, 2009
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphomaAjay K Gopal, John M Pagel, Jonathan R Fromm, et al.
Pageof 25

Showing results (51-60 of 245) with videos related to

Sort By:
Pageof 25
Journal of Molecular Biology|April 20, 1992
DNA topology-mediated regulation of transcription initiation from the tandem promoters of the ilvGMEDA operon of Escherichia coliJ M Pagel, J W Winkelman, C W Adams, et al.
Hemasphere|November 15, 2019
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia - Passé Yet?Alexey V Danilov, John M Pagel, Jennifer R Brown, et al.
Analytical Chemistry|November 24, 1999
Mass spectrometric analysis of benzoylated sialooligosaccharides and differentiation of terminal alpha 2-->3 and alpha 2-->6 sialogalactosylated linkages at subpicomole levelsP Chen, U Werner-Zwanziger, D Wiesler, et al.
Cancer Research|November 1, 1981
Pharmacology and toxicity of intracarotid adriamycin administration following osmotic blood-brain barrier modificationE A Neuwelt, M Pagel, P Barnett, et al.
Neurosurgery|January 1, 1983
Inability of dimethyl sulfoxide and 5-fluorouracil to open the blood-brain barrierE A Neuwelt, P Barnett, J Barranger, et al.
American Journal of Hematology|August 19, 2007
Therapeutic use of Rituximab for sinus histiocytosis with massive lymphadenopathy (Rosai-Dorfman disease)John M Pagel, Jack Lionberger, Ajay K Gopal, et al.
Chemical Research in Toxicology|July 22, 1998
Reaction of N-acetylglycyllysine methyl ester with 2-alkenals: an alternative model for covalent modification of proteinsA Baker, L Zídek, D Wiesler, et al.
Cancer Research|April 6, 2006
A genetically engineered anti-CD45 single-chain antibody-streptavidin fusion protein for pretargeted radioimmunotherapy of hematologic malignanciesYukang Lin, John M Pagel, Donald Axworthy, et al.
Proceedings of Spie--The International Society for Optical Engineering|October 1, 2016
Multimodality pH imaging in a mouse dorsal skin fold window chamber modelHui Min Leung, Rachel Schafer, Mark M Pagel, et al.
Blood|April 1, 2009
131I anti-CD45 radioimmunotherapy effectively targets and treats T-cell non-Hodgkin lymphomaAjay K Gopal, John M Pagel, Jonathan R Fromm, et al.
Pageof 25